Paraneoplastic cerebellar degeneration (PCD) is a heterogeneous group of disorders characterised by subacute cerebellar ataxia, specific tumour types and (often) associated anti-neuronal antibodies (of which there have been 9 characterised.) Initial screen includes Yo and Ri; the following antibodies are available.
Please include full clinical details to ensure the most appropriate antibodies are tested.
|Sample & container required||RST (rust top), Gel SST (yellow top), Can also be performed on CSF|
|Sample volume||5 -10 mL (1 mL serum)|
|Turnaround time||14 days|
This test is currently unaccredited due to a recent change in platform.